# Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers

> **NCT04497805** · PHASE2 · UNKNOWN · sponsor: **Anterogen Co., Ltd.** · enrollment: 64 (estimated)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **BIOLOGICAL:** ALLO-ASC-SHEET

## Key facts

- **NCT ID:** NCT04497805
- **Lead sponsor:** Anterogen Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-08
- **Primary completion:** 2024-12
- **Final completion:** 2025-06
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2023-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04497805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04497805, "Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04497805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*